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D
rug formulation is one of the most
crucial tasks in pharmaceutical tech-
nology, as many potent drugs are
not water-soluble in applicable quantities.
To deliver drugs, several formulation vehi-
cles such as nano- and microparticles,1
liposomes,1,2 and polymeric micelles37
have been investigated. To facilitate treat-
ment, a high capacity of these vehicles for
the active pharmaceutical ingredient is de-
sirable, as it allows a smaller volume of the
formulation and a smaller amount of exci-
pient to reach an effective dose. Paclitaxel
(PTX), a potent cytostatic drug for a wide
range of tumors, is one of these drugs with
very low water solubility of approximately
1 μg/mL.25 However, a formulation (Taxol)
first approved by the U.S. Food and Drug
Administration (FDA) contains less than
1 wt % of PTX and uses high concentrations
of the cosolvents ethanol and Cremophor
EL needed to solubilize adequate amounts
of PTX. This vehicle may induce a life-threa-
tening hypersensitivity. Nevertheless, Taxol
is still commonly used to treat breast, ovarian,
and non-small-cell lung (NSCL) cancers.8,9 In
2005, the FDA approved an albumin-bound
PTX (Abraxane), which contains 10 wt % of
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ABSTRACT Defined aggregates of polymers such as polymeric micelles are of great
importance in the development of pharmaceutical formulations. The amount of drug
that can be formulated by a drug delivery system is an important issue, and most drug
delivery systems suffer from their relatively low drug-loading capacity. However, as the
loading capacities increase, i.e., promoted by good drugpolymer interactions, the
drug may affect the morphology and stability of the micellar system. We investigated
this effect in a prominent system with very high capacity for hydrophobic drugs and
found extraordinary stability as well as a profound morphology change upon
incorporation of paclitaxel into micelles of amphiphilic ABA poly(2-oxazoline) triblock
copolymers. The hydrophilic blocks A comprised poly(2-methyl-2-oxazoline), while the middle blocks B were either just barely hydrophobic poly(2-n-butyl-
2-oxazoline) or highly hydrophobic poly(2-n-nonyl-2-oxazoline). The aggregation behavior of both polymers and their formulations with varying paclitaxel
contents were investigated by means of dynamic light scattering, atomic force microscopy, (cryogenic) transmission electron microscopy, and small-angle
neutron scattering. While without drug, wormlike micelles were present, after incorporation of small amounts of drugs only spherical morphologies
remained. Furthermore, the much more hydrophobic poly(2-n-nonyl-2-oxazoline)-containing triblock copolymer exhibited only half the capacity for
paclitaxel than the poly(2-n-butyl-2-oxazoline)-containing copolymer along with a lower stability. In the latter, contents of paclitaxel of 8 wt % or higher
resulted in a raspberry-like micellar core.
KEYWORDS: amphiphilic poly(2-oxazoline)s . paclitaxel . drug delivery . rod-to-sphere transition
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the active drug. It is approved for the treatment of
breast and NSCL cancers that have metastasized,
recurred, or cannot be treated with radiation therapy
or surgery.10 In previous publications, we presented
amphiphilic poly(2-oxazoline)s (POx, Figure 1) as a
drug delivery platform with low toxicity, low comple-
ment activation, and very high loading capacities for a
variety of hydrophobic drugs.1115 With several drugs
but especially with PTX, docetaxel (DTX), and 17-ally-
lamino-17-demethoxygeldanamycin (17-AAG) long-
term stable micellar formulations were obtained, with
no significant changes of the micellar size or size
distribution over a time period of at least 14 days.16
Moreover, the POxdrug micellar formulations can be
freeze-dried and rehydrolyzed without a change in the
drug-loading capacity, micellar size, particle dispersity,
or in vitro drug activity.11
These POx micelles not only allow unprecedented
high incorporation of nearly 50 wt % PTX but also
achieve high loading capacities for multiple other
drugs such as 17-AAG, etoposide, and bortezomib
and their combinations of up to three agents
simultaneously.16 During these investigations, it be-
came apparent that, although drugs such as PTX are
hydrophobic, a pronounced hydrophobicity of the
hydrophobic block is not necessarily beneficial for drug
solubilization. Experiments with the fluorescent probe
pyrene revealed a surprisingly polar environmentwith-
in the micellar core of amphiphilic block copolymers
comprising a poly(2-n-butyl-2-oxazoline) (PBuOx)
block.11,17 BuOx is the first hydrophobic POx in the
homologue series of poly(2-alkyl-2-oxazoline)s, and
the short n-butyl side chains are probably not sufficient
to shield the repeating polar amide motif in each
monomer unit of the polymer backbone. In contrast,
poly(2-n-nonyl-2-oxazoline) (PNOx) comprising micel-
lar cores exhibit a nonpolar environment expected in
micelles.11,1820 We hypothesize that the highly polar
BuOx core offers a highly suitable environment for the
hydrophobic PTX with its many polar groups. Here, we
report that the increase in the hydrophobicity of the
middle block B, from barely hydrophobic BuOx to
highly hydrophobic NOx, decreases the solubilization
capacity for PTX by more than half. To understand this
phenomenon, we investigated the morphologies of
both polymer aggregates and their formulations with
PTX by dynamic light scattering (DLS), atomic force
microscopy (AFM), (cryo-) transmission electron micro-
scopy ((cryo-)TEM), and small-angle neutron scattering
(SANS). Moreover, the results reveal that the mutual
interactions between drug and carrier strongly influ-
encemorphology, loading capacity, and stability of the
drug-loaded micelles.
RESULTS
Polymer Characterization and Drug Solubilization Capacity.
The nature of the hydrophobic core in polymer mi-
celles may influence the drug loading. For example,
while amphiphilic block copolymers containing barely
hydrophobic BuOx blocks promoted the solubilization
of PTX extraordinarily well, Luxenhofer et al.11 also
observed that an amphiphilic diblock copolymer with
a strongly hydrophobic NOx block (P(MeOx32-b-NOx9))
only solubilized a fraction (7 wt %). To investigate the
differences between the two types of polymers inmore
detail, we compare here triblock copolymers with
similar hydrophilic/lipophilic balances, but different
structures of the hydrophobic block (BuOx vs NOx).
Both ABA triblock copolymers were synthesized by
means of living cationic ring-opening polymeriza-
tion, allowing control over polymer composition and
narrow polymer dispersity ^ (Mw/Mn) (Table 1). The
triblock copolymer P(MeOx-b-NOx-b-MeOx) was pre-
pared in two batches (P10, P100). For the sake of read-
ability, we will not distinguish between the two
batches and will refer to both polymers as P1, since
we did not observe any significant differences in their
physicochemical behavior and drug formulation.
The new batch of P(MeOx-b-BuOx-b-MeOx) (P2)
displayed the same extraordinary loading capacity of
PTX (49 wt %) as its predecessors, while the triblock
copolymer P1 had a slightly better loading capacity
(24 wt %) as compared to the diblock copolymer
containingNOx reported earlier (Figure 2).We attribute
this to the different architecture (AB vs ABA). First, we
investigated the drug solubilization with respect to the
drug feed. Interestingly, when increasing the PTX feed/
Figure 1. Chemical structure of amphiphilic poly(2-oxazoline)s
and their schematic self-assembly to micelles.
TABLE 1. Characterization Data of ABA Triblock Co-
polymers Used in This Study
polymer compositiona Mn
b [kg/mol] Mn
c [kg/mol] ^
P10 P[MeOx35-b-NOx14-b-MeOx35] 8.8 8.7 1.28
P100 P[MeOx34-b-NOx12-b-MeOx37] 8.5 9.2 1.14
P2 P[MeOx33-b-BuOx26-b-MeOx45] 10.0 11.4 1.14
a MeOx: 2-methyl-2-oxazoline, BuOx: 2-butyl-2-oxazoline, NOx: 2-nonyl-2-oxazoline.
b As determined by end group analysis from 1H NMR spectroscopy. c As determined by
gel permeation chromatography.
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POx ratio in the drugpolymer film during prepara-
tion, the efficiency of P1 to solubilize PTX was initially
similar to that of P2, but dropped sharply above a ratio
of 1:5 (w/w). Even more, the solubilized PTX content in
the final aqueous solutions was less than in solutions
prepared with lower feeding concentrations of PTX.
The same phenomenonwas observed for P2; however,
the oversaturation of the thin film occurred only with
PTX/P2 feed ratios above 1.
Aggregation Behavior Studied by DLS. Earlier studies on
the aggregation behavior of a P(MeOx30-b-NOx7-b-
MeOx26) triblock copolymer using fluorescence correla-
tion spectroscopy revealed micelles with a hydrodynamic
radius of around 5.6 nm in deionized water.21 Here, we
found similar hydrodynamic radii of the micelles in
buffer solution, for both polymers at 10 g/L (Rh,mic(P1) =
8.3 ( 0.1 nm; Rh,mic(P2) = 15.3 ( 0.7 nm). However,
both P1 and P2 also formed larger aggregates in solu-
tion as well (Rh,agg(P1) = 207( 28 nm; Rh,agg(P2) = 79(
25 nm) (Figure 3).
With the introduction of small quantities of PTX, the
micelles became smaller and more defined, as evi-
denced by the reduced width of the peaks in the
distribution of hydrodynamic radii (Figure 4). Already
the presence of 3 wt % PTX (0.3 g/L) was sufficient to
suppress formation of aggregates in an aqueous solu-
tion of P1. However, at a PTX content of 14.5 wt %
(c(PTX) = 1.7 g/L) the micelles more than doubled in
size (Rh,mic(P1þPTX) = 26.8( 0.2 nm) in comparison to
the unloaded micelles. The same trend was observed
for P2; at a maximum loading capacity of 49 wt % the
largest Rh value was observed with Rh,mic(P2þPTX) =
23.8( 0.3 nm. Since P2 can solubilize much more PTX,
the tendencies of initial compaction and subsequent
growth of the micelles with increasing PTX concentra-
tion were better observable for this polymer (Figure 4).
Again, dissolution of all larger aggregates was ob-
served upon the addition of PTX, however in the case
of P2 only at PTX contentsg 9 wt % (g1.01 g/L). Bonné
et al.22,23 described that large metastable aggregates
for short P(MeOx-b-NOx) block copolymers at room
temperature (RT) vanished after annealing the polymer
solution above 40 C. To verify that in our system the
Figure 2. Solubilized PTX (bars; P1 striped; P2 solid, left axis)
and loading efficiencies (P1dashed line; P2 dotted line, right
axis) of polymers P1 and P2 (10 g/L) at different PTX feeds.
Data are presented as means ( SEM (n = 35).
Figure 3. Rh of micelles (open square) and aggregates (circle) of P1 (left) and P2 (right) without and with PTX. Rh values were
determinedbymultiangle light scattering (30150). The scattering contribution ofmicelles (solid square) is derived from the
measurement angle 90. The polymer concentration was kept constant at 10 g/L. The dotted lines are added as guidance for
the eye.
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disappearance of the larger aggregateswas not caused
by the PTX solubilization procedure, which is carried
out at 55 C for 45 min, we carried out DLS measure-
ments in aqueous solutions of the polymers alone
that had been heated to 60 C for over 1 h. Indeed,
the scattering contribution of themicelles did increase,
but the large aggregates did not dissolve completely
(data not shown). It appears that in the described
system the incorporation of PTX influences the aggre-
gation of the polymers more than thermal treatment.
Obviously the formation of small and well-defined
micelles can be optimized by variation of the drug
concentration. This effect is dependent on the nature
of the hydrophobic block of the amphiphilic block
copolymer.
Long-Term Stability of the PTX Formulations. In previous
studies, we reported on the good stability of POx
drug formulations including the here described P2.
Especially with taxanes (PTX and DTX) and 17-AAG,
stable formulations were obtained with no noticeable
change of the micellar size and particle dispersity for
at least 14 days.16 Here, we present results of a direct
comparison of the P1/PTX and P2/PTX formulation at
theirmaximumpossible drug content of 1.7 g/L PTX for
P1 and 9.9 g/L for P2, respectively. The formulations
were examined by eye inspection for precipitation of
drug as well as by DLS to determine the development
of aggregate sizes and dispersity with time. The results
are summarized in Figure 5.
For P1/PTX excellent stability was observed, but
the first changes became noticeable after 4 weeks of
storage under ambient conditions. DLS indicated the
formation of larger aggregates, and after 3months, the
formulation became so heterodisperse that a reason-
able fit of the autocorrelation function was impossible.
Moreover, some drug precipitated, and centrifugation
and analysis of the clear supernatant solution resulted
in a remaining PTX content of 1.4 g/L. For the P2/PTX
formulation, no changes of the formulation appear-
ance, micellar size, or particle dispersity were detect-
able even after 7 months of storage under ambient
conditions. As shown in Figure 5, the autocorrelation
function of the P2/PTX formulation did not change
over a time course of more than half a year. A routine
Figure 4. Unweighted distribution of the hydrodynamic radii Rh of P1 (left) and P2 (right) with varying concentrations of PTX
and a polymer concentration of 10 g/L determined by DLS at 90.
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check of the drug content (centrifugation and analysis
of the clear solution) after 3 months resulted in 9.8 g/L
PTX, which is within the experimental error.
Aggregate Characterization by AFM and (Cryo-)TEM. While
DLS gave information about the size of themicelles and
aggregates, AFM was utilized to visualize their shape. It
is important to note that, despite various attempts, we
were unable to visualizemicelles formed by bare P1 and
P2. This is attributed to their disintegrationupon contact
with the surface or removal during washing. Only after
the introduction of PTX, we were able to visualize the
aggregates upon deposition on the surface (Figure 6).
The resulting AFM scans support the previously
discussed DLS data. With sufficiently high PTX content,
both P1 and P2 displayed uniform spheres (Figure 6a
and c) of approximately 5 nm in height and 4050 nm
in diameter. The deviation in size as compared to DLS
data is attributed to the distortion of the micelles upon
deposition and subsequent drying as well as to the
choice of the AFM tip. Notably, P2 containing 3 wt %
PTX displayed wormlike micelles (Figure 6b and d).
To verify if the wormlike micelles are also formed in
the absence of PTX and to confirm their dissolution
upon drug incorporation, the polymers were investi-
gated by TEM as well. The TEM image of negatively
stained P1 shows homogeneous spherical micelles
with only a few wormlike structures (Figure 7a), which
disappear completely upon introduction of PTX (image
not shown).
The image quality (Figure 7a) allowed analyzing the
shape of the structures via image analysis software.
The resulting regions of interest (ROIs) were fur-
ther sorted by their circularity. Regions with a circu-
larity above 4 (strong ellipsoidal form) were not
included into the calculation of themicelle size, since
those objects were attributed to the aggregation of
micelles, which the employed image analysis algo-
rithm could not distinguish due to insufficient
threshold values in those regions. When converting
the pixels into nanometers, an average radius of 4.6
( 1.2 nm for P1 was calculated. Not surprisingly, this
value is smaller than the radius determined via DLS
(Rh(P1) = 8.3( 0.1 nm). This is attributed to the loss of
the hydration shell during drying. The TEM images of
bare P2 (Figure 7b) and of P2 with PTX (image not
shown) were not sufficient in quality for analysis via
Figure 5. Long-term stability study for P1/PTX and P2/PTX formulations at maximum loading conditions as determined by
DLS at indicated lengths of storage time. Development of the unweighted size distribution of Rh of P1/PTX (10/1.7 g/L, above)
and P2/PTX (10/9.9 g/L, below) and their corresponding intensity autocorrelation functions (right) over time. For better
visibility only selected size distributions are shown with a y-offset of 0.1.
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image analysis software. Thus, the ROIs were manu-
ally defined. The size of P2 micelles at 6.7( 1.1 nm is
slightly larger than that of P1 micelles, which corro-
borates the DLS results. The wormlike micelles are
also discernible for bare P2 and their disappearance
upon introduction of PTX. The data are summarized
in Table 2.
To overcome the effects of sample preparation that
might induce artifacts due to the staining and drying
procedure and to obtain images of improved quality,
bare solutions of P2 and P2 with PTX (10 and 5 g/L)
were investigated by cryo-TEM. Again, coexistence of
wormlike structures and spherical micelles was ob-
served when P2 was prepared alone. Upon incorpora-
tion of PTX, exclusively spherical micelles were ob-
served (Figure 8).
At higher magnification the coreshell structure
of the drug-loaded P2 micelles is clearly discernible
(Figure 8b). In comparison to the images obtained for
bare P2, the incorporation of PTX apparently increases
the electron density defining the core perimeter.
Again, the ROIs were manually defined. Subsequently,
the size analysis of both the core and the micelles was
performed (Table 2).
Figure 6. AFM height scans and corresponding height profiles prepared from solutions of P1/PTX (10/0.2 g/L) (a); P2/PTX
(10/0.2 g/L) (b, d); and P2/PTX (10/5 g/L) (c) diluted immediately 1001000 times prior to deposition on a freshly cleavedmica
surface.
Figure 7. TEM images of uranyl acetate stained P1 (a) and P2 (b).
TABLE 2. Dimensions (nm) of Spherical and Wormlike
Micelles of P1 and P2 and Their Drug Formulations
Obtained by Image Analysis of Negatively Stained
(TEM) and Vitrified (cryo-TEM) Samples
P1 P1/PTX 17 wt % P2 P2/PTX 30 wt %
TEM TEM TEM cryo-TEM TEM cryo-TEM
Rcore 6.1 ( 1.2
Rmic 4.6 ( 1.2 4.2 ( 0.6 6.7 ( 1.1 13.5 ( 2.2 5.2 ( 0.8 13.2 ( 2.8
Lworms 34152 3070 3470
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Small-Angle Neutron Scattering. To better understand
the process of incorporation of such large quantities of
PTX into the BuOx core (as opposed to the limited
uptake in NOx), we briefly present results obtained by
small-angle neutron scattering on a concentration
series of PTX with a constant amount of P2 (10 g/L in
D2O). The micelles from bare P2 and up to PTX
concentrations of 5 g/L (32 wt %) were found to be
spheres with radii of 46 nm, which excellently corre-
late with the size of the micellar core found in cryo-TEM
measurement (Figure 9). In our present setupof the SANS
experiment, the micellar shell was not resolved because
of its strong hydration and its resulting low scattering
contrast with respect to the solvent. Also, the contribu-
tion of wormlike micelles was not deconvoluted.
The scattering profile from solutions with more
than 8 wt % PTX (0.9 g/L) could not be adequately
modeled by homogeneous spheres, but rather by a
raspberry-like sphere as depicted in Figure 9. We
interpret this as reflecting the presence of PTX-rich
domains in the polymer micelles. The radius of the
particles RPTX embedded into the micellar core in-
creased along with the PTX concentration from
1.2 nm to 1.7 nm. The details of the quite complex
fitting procedure of the SANS data are discussed else-
where, as it requires a detailed presentation and is, as
such, beyond the scope of this paper.24,25
DISCUSSION
Polymeric micelles play an important role in nano-
medicine as highly versatile drug delivery systems. We
used such micelles based on poly(2-oxazoline) to
solubilize unprecedented high loading contents of
the anticancer drug paclitaxel (45 wt %). Since then,
various other high-capacity micellar drug delivery
systems for taxanes (2936 wt %) have been reported
in the literature.2628 However, with the increasing
success of realizing high-capacity drug formulations,
it becomes important to analyze the effects of the
incorporated drug on the morphology and stability
of the system. Changes in the aggregation behavior
of amphiphilic polymers upon drug incorporation have
been previously reported for pluronic and other
systems.2932 Depending on the nature of the drug,
the micelles increased29 or decreased30 in size. More
interestingly, drugs also induced sphere-to-rod transi-
tions, where the incorporated drug shifted the balance
from spherical toward wormlike micelles.31,32 In the
past decade, wormlike micelles have gained increased
interest as a drug delivery system due to their en-
hanced circulation time in vivo and increased loading
capacities.3336 The presently studied triblock copoly-
mers P[MeOx-b-BuOx-b-MeOx] and P[MeOx-b-NOx-b-
MeOx] form predominantly spherical micelles with
only a small fraction of wormlike micelles. However,
the incorporation of PTX did not facilitate the forma-
tion of these wormlikemicelles, but rather caused their
disintegration. To the best of our knowledge, drug-
induced rod-to-sphere transitions have so far not been
reported in the literature. Tan et al. demonstrated on
the basis of multiblock polyurethane micelles that
defects in themicellar shell, leading to partial exposure
of the hydrophobic core, initiated sphere-to-rod transi-
tion.37 In the case of P[MeOx-b-BuOx-b-MeOx], the inclu-
sion of PTX seems to compact the micelles for PTX
contents up to 32 wt %. Applying the approach of Tan
et al.37 to our system, the induced compaction of the
micellar core by PTX reduces the probability of hydro-
phobic chains being exposed on the micelle surface, thus
preventing the formation of wormlike structures.
Nevertheless, at maximum drug loading both sys-
tems remained stable for a long time. While for P1 the
first changes became noticeable after 4 weeks, the
P2/PTX formulation displayed no measurable changes
for more than half a year. This can be explained by the
very effective nonpolar as well as polar drugpolymer
interactions. Further increase in drug concentration
above the critical loading capacity lead ultimately to
Figure 8. Cryo-TEM images of P2 (10 g/L) (a) and P2/PTX (10/5 g/L) (b). Insets show the indicated region at higher
magnification.
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a collapse in loading efficiency. While the drop occurs
for the P[MeOx-b-NOx-b-MeOx] copolymer already at
PTX contents of 23 wt %, P[MeOx-b-BuOx-b-MeOx] can
be reproducibly loaded with up to 49 wt % PTX. In
contrast to a NOx core, BuOx exhibits a considerably
lower crystalline volume fraction, and the amorphous
phase is well above its Tg of BuOx during the PTX
solubilization process.38 The increased mobility of the
chains within the core might make themmore suitable
to accommodate higher quantities of PTX.
The SANS experiments revealed intricate structural
changes within the micelle of P[MeOx-b-BuOx-b-
MeOx] upon the addition of PTX. While the scattering
model suggests homogeneous spheres in the absence
of PTX, small domains, likely comprising PTX, become
apparent after the addition of PTX. These domains are
embedded into the micellar core at an average em-
bedment depth δ of approximately 0.3 nm, which
means that they are partially submerged into the core
rather than clinging as separate particles to the sur-
face. Together with the relative surface coverage of the
domains of 0.760.92, we can envision that the
PTX-loaded P2 micelles have a core whose surface is
covered by PTX-rich domains, which are partially em-
bedded into the core. However, the domain size lies
between 1 and 2molecular diameters of PTX, and thus,
even at high loading of PTX, the drug is not incorpo-
rated in the bulk state but molecularly dispersed and
associated with polymer chains via nonpolar as well as
polar interactions. This picture of PTX incorporation in
the core is further corroborated by thermal analysis
using differential scanning calorimetry (DSC, data not
shown). DSC gave only the glass transition for the
hydrophilic MeOx blocks of P1 or P2 ((P1/PTX19wt%) =
73 C; Tg(P2/PTX49wt%) = 76 C)). The hydrophobic part
of the micelles (NOx or BuOx block and PTX) does not
give rise to a glass or melting transition between 0 C
and decomposition.
CONCLUSION
The present study establishes a strong influence of
the anticancer drug PTX on the morphology of poly-
(2-oxazoline)-based micelles. In aqueous solution, the
investigated amphiphilic triblock copolymers partially
form wormlike micelles. Wormlike micelles, or “filomi-
celles”, are currently discussed as promising drug
carriers with significantly improved blood circulation
times, faster endocytosis, and improved anticancer
activity.39 However, drug loading of the presented
triblock copolymers leads to amorphology switch from
partly filomicelles to exclusively spherical micelles.
They were found to be long-term stable for over half
a year, well-defined, and even at high loading condi-
tions very small. In a recent study, Kataoka et al.40
presented a conclusive study on the size effect of
micellar drug delivery systems. It was shown that
anticancer drug formulations of small micellar sizes
are a prerequisite for the treatment of poorly perme-
able solid tumors. At increasing PTX concentration,
localization of drug nanoparticles at the coreshell
interface results in a micellar core with a raspberry-like
structure. These results indicate the importance of the
thorough characterization of drug carriers after drug
loading, especially when pushing the limit to high-
capacity systems.35,36 As the loading capacity and
stability of the drug-loaded systems represent a critical
aspect in micellar drug delivery, the present study
provides important insights for the development of
other drug delivery systems to optimize their drug
delivery capabilities and stabilities.
MATERIALS AND METHODS
All chemicals were purchased from Acros Organics (Geel,
Belgium) and Sigma-Aldrich (Munich, Germany) and were used
as received unless otherwise stated. Deuterated solvents for
NMR analysis were obtained from Deutero GmbH (Kastellaun,
Germany). PTX was purchased at LC Laboratories (Woburn, MA,
Figure 9. (a) Scattering curves of bare P2 (10g/L, blue) andP2with PTX (10 and4.8 g/L, red) and theirfitting curves assuminga
homogeneous sphere (solid line) or a raspberry form (dashed line). Curves are shifted in intensity for better visibility. (b) All
radii from SANSmeasurements of P2 solutions in D2O (c = 10 g/L at 37 C) with varying PTX concentrations. Sketches indicate
if homogeneous spheres or raspberry-like micelles were applied for the fitting process. Open circles: radii of spherical
micelles, solid circles: radii of raspberry-like micelles, Rmic, open triangles: radii of the embedded PTX particles, RPTX.
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USA). Phosphate-buffered saline (PBS) was prepared by dissol-
ving one tablet (Fluka, 79382) in 200 mL of H2Odd to obtain a
137mMNaCl, 2.7mMKCl, and 10mMphosphate buffer solution
(pH 7.4 at 25 C). NOx was received as a gift from Henkel KGaA
(Düsseldorf, Germany). BuOx was prepared following the pro-
cedure by Huber et al.41 All substances used for polymerization,
methyl trifluoromethylsulfonate (MeOTf), MeOx, BuOx, NOx,
chlorobenzene (ClBz), and acetonitrile (ACN), were refluxed
over CaH2 and distilled under nitrogen. NMR spectra were
recorded on a Bruker DRX 500 P (1H: 500.13 MHz) at RT. The
spectra were calibrated to the signals of residual protonated
solvent signals (ACN: 1.94 ppm, MeOD: 3.31 ppm). Gel permea-
tion chromatography (GPC) was performed on a Polymer
Laboratories GPC-120 (column setup: 1 PSS GRAM analytical
1000 and 1 PSS GRAM analytical 100 obtained from Polymer
Standards Services,Mainz,Germany)withN,N-dimethyl acetamide
(DMAc) (5mmol/L LiBr, 1wt%H2O, 70 C, 1mL/min) as eluent and
poly(methyl methacrylate) standards. Microwave-supported poly-
merization was performed using a CEM Discover microwave.
Polymer Synthesis. Living Cationic Ring-Opening Polymeriza-
tion. Under dry and inert conditions, 1 equiv of MeOTf and
35 equiv of MeOx were dissolved in dry ACN/ClBz (50/50, v/v) at
RT. The reaction mixture was irradiated in the microwave for
60 min at 150 W and 100 C (P1': 10 min, 150 W, 130 C). After
cooling to RT 20 equiv/13 equiv BuOx/NOxwere added, and the
mixture was irradiated for another 60 min (P1': 10 min). The
procedure was repeated with 35 equiv of MeOx. Termination
was carried out with 3 equiv of 1-BOC-piperazine in ClBz for 1 h,
50 W and 40 C. An excess of potassium carbonate was added,
and themixture was stirred for several hours. After filtration, the
mixture was concentrated, added into a mixture of chloroform
and methanol (75/25, v/v), and precipitated in cold diethyl
ether. After centrifugation and removal of diethyl ether the
precipitation was repeated one more time. The residue was
lyophilized, and a colorless powder was obtained.
Deprotection. The obtained polymer was dissolved either in
a mixture of trifluoroacetic acid (TFA), triisobutylsilane (TIBS),
and water (95/2.5/2.5, v/v/v) or in chloroform, methanol, and
phosphoric acid (25/50/25, v/v/v) and stirred for 1 h and over-
night at RT, respectively. The volatiles were removed under
fine vacuum. The residue was dissolved in deionized water (if
necessary neutralized with sodium hydroxide and salts re-
moved after lyophilization in ACN), transferred into a dialysis
bag (MWCO 3500 g/mol), and dialyzed against deionized water.
The solution was recovered from the bag and lyophilized, and a
colorless powder was obtained.
Methyl-P[MeOx35-b-NOx14-b-MeOx35]-piperazine (P1
0):. 21.4
mg (0.13 mmol, 1 equiv) of MeOTf, 0.40 g (4.71 mmol, 36 equiv)
ofMeOx, 0.34 g (1.70mmol, 13 equiv) of NOx, 0.39 g (4.62mmol,
36 equiv) of MeOx, and 75.0 mg (4.03 mmol, 3 equiv) of 1-BOC-
piperazine. A colorless powder was obtained (0.79 g, 72%). GPC
(DMAc): Mn = 11.8 kg/mol (^ = 1.13). A 0.50 g amount of the
polymer was deprotected with 3 mL of TFA/TIBS/H2O. A 0.46 g
(92%) yield of a colorless powder was obtained. GPC (DMAc):
Mn = 8.7 kg/mol (^ = 1.28).
1H NMR (MeOD, 300 K): δ [ppm] 3.53 (m, 334H, N-CH2CH2);
3.10/3.06/2.95 (m, 3H, N-CH3
Ini); 2.752.33(m, 33H, CO-CH2nonyl,
CH2
Pip); 2.152.09 (m, 210H, CO-CH3); 1.59 (br, 28H, CH2-CH2-
CH2); 1.31 (br, 168H, CH2); 0.91 (br, 41H, CH3nonyl).
Methyl-P[MeOx35-b-NOx11-b-MeOx36]-piperazine (P1
00):. 0.19 g
(1.17 mmol, 1 equiv) of MeOTf, 3.49 g (0.04 mol, 35 equiv) of
MeOx, 2.69 g (0.01 mol, 12 equiv) of NOx, 3.37 g (0.04 mmol,
34 equiv) of MeOx, and 0.70 g (4.03 mmol, 3 equiv) of 1-BOC-
piperazine. A colorless powder was obtained (7.85 g, 79%). GPC
(DMAc): Mn = 9.5 kg/mol (^ = 1.17). A 7.70 g amount of the
polymer was deprotected with 20 mL of CHCl3/MeOH/H3PO4. A
4.51 g (59%) yield of a colorless powder was obtained. GPC
(DMAc): Mn = 9.2 kg/mol (^ = 1.14).
1H NMR (ACN, 300 K): δ [ppm] 3.38 (br, 334H, N-CH2CH2);
2.99/2.96/2.84 (m, 3H, N-CH3
Ini); 2.472.22(m, 31H, CO-CH2nonyl,
CH2
Pip); 2.041.98 (m, 213H, CO-CH3); 1.51 (br, 24H, CH2-CH2-
CH2); 1.41 (br, 5H, CH3BOC); 1.27 (br, 141H, CH2); 0.88 (br,
34H, CH3
nonyl).
Methyl-P[MeOx33-b-BuOx26-b-MeOx45]-piperazine (P2):. 0.30 g
(1.82 mmol, 1 equiv) of MeOTf, 5.44 g (63.9 mmol, 35 equiv) of
MeOx, 4.57 g (35.9 mmol, 20 equiv) of BuOx, 5.34 g (62.7 mmol,
34 equiv) ofMeOx, 1.03 g (5.6mmol, 3 equiv) of 1-BOC-piperazine.
A colorless powder (13.65 g, 82%)was obtained. GPC (DMAc):Mn =
10.6 kg/mol (^ = 1.16). A 9.92 g amount of the obtained polymer
was deprotected with 60 mL with TFA/TIBS/H2O. A 7.19 g (72%)
yield of a colorless powder was obtained. GPC (DMAc): Mn = 11.4
kg/mol (^ = 1.14).
1H NMR (ACN, 300 K): δ [ppm] 3.43 (br, 418H, N-CH2CH2);
2.98/2.84 (m, 3H, N-CH3
Ini); 2.332.22 (m,86 H, CO-CH2butyl,
CH2
Pip); 2.041.08 (m, 241H, CO-CH3); 1.51 (br, 51H, CH2-CH2-
CH2); 1.31 (br, 52 H, CH2-CH3); 0.89 (br, 77 H, CH3butyl).
Paclitaxel Solubilization. Ethanolic stock solutions were mixed
in desired ratios. Ethanol was evaporated with the help of a
steady hot air flow (100 C, ∼20 min). The generated thin films
were further dried for >10 min in vacuo to ensure complete
removal of the solvent. After the addition of PBS, the solu-
tions were heated to 55 C and shaken at 10001200 rpm for
3045minwith the help of a thermoshaker. Nonsolubilized PTX
(if any) was removed via centrifugation (10 000 min1, 10 min).
The quantification was performed on a Varian 920-LC HPLCwith
a stepwise gradient using a Kinetex 2.6 μm PFP, 100 4.60 mm
column by Phenomenex at RT and UV detection at 254 nm.
Within the first 15 min, the ratio of H2O/MeOH (40/60, v/v) was
decreased to 5:95, followed by 10 min purging of the column
with 95% MeOH and subsequent reversion of the ratio to the
start settings. The loading capacity (LC) is defined as themass of
solubilized PTX divided by the total mass (LC = mPTX/mtotal),
while the loading efficiency (LE) is the percentage of solubilized
PTX from the original PTX feed (LE = (mPTX/mPTX,0) 100%). The
POx concentration was kept constant at 10 g/L for all solubiliza-
tion experiments. Solubilization experiments were repeated
3 to 5 times, and results are presented as means ( standard
error of the mean (SEM).
Dynamic Light Scattering. The DLS experiments were per-
formed on an ALV/DLS/SLS-5000 compact goniometer system
with an ALV/SO-SIPD/DUAL photomultiplier detection unit and
a JDS Uniphase HeNe-laser with a wavelength λ = 632.8 nm
used at 22mW. The toluene bathwas temperature controlled by
a Julabo thermostat and kept constant at 25 C. Angle-depen-
dent measurements were performed between 30 and 150 in
5 steps with a measurement time of 120 s.
Polymer solutions were prepared in PBS. The polymer
concentration was kept constant at 10 g/L, while the PTX
concentration ranged from 0 to 9.9 g/L. All solutions were
filtered (0.45 μm PVDF), and PTX content was determined prior
to measurement via HPLC.
The DLS data were evaluated according to Schärtl.42 The
field autocorrelation functions were either modeled with a
stretched exponential form,
g1(τ) ¼ b exp( Γτ)β (2)
for stretched exponents β g 0.9 assuming a monomodal
distributions or fitted with a double-exponential function
(polydisperse sample).
g1(τ) ¼ bmic exp( Γmicτ)þ bagg exp( Γaggτ) (1)
Here bmic and bagg are the relative scattering contributions from
different species (micelles and aggregates), respectively, while
Γ is the decay rate of the respective correlation functions.
The obtained decay rates are related to the diffusion
coefficient D via
Γ ¼ Dq2 (3)
where q is the scattering vector with q = 4π sin(θ/2)/λ and θ the
scattering angle. To test the validity of amonomodal or bimodal
assumption, we checked whether Γ  q2 and whether the
extrapolation of the data to q = 0 gave Γ = 0.
From the resulting diffusion coefficient, we calculated the
hydrodynamic radii according to the StokesEinstein relation
Rh ¼ kBT6πηD (4)
where kB is Boltzmann's constant, T the temperature, and η the
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viscosity of the solvent. Uncertainties of Rh were derived
from the confidence interval of 99% of the regression lines.
The distribution of Rh at θ = 90 was obtained by a regular-
ized inverse Laplace transformation algorithm;which is
incorporated in the ALV-5000 program;of the correlation
function.
Atomic Force Microscopy. The AFM scanswere obtainedwith an
NT-MDT NTEGRA Spectra system. All scans were performed
in tapping mode with standard AFM tips (NSG03/NT-MDT)
under ambient conditions. The sample solutions were diluted
(1001000 times) immediately prior to deposition on the
freshly cleavedmica surface and incubated for <1min. Depend-
ing on the dilution, the surface was additionally washed with a
drop of DI water or dried under an argon atmosphere right
away. The stock solutions contained 10 g/L POx and varying
concentrations of PTX (0.25.0 g/L). The data were processed
with the Gwyddion 2.3 freeware.
Transmission Electron Microscopy. Vitrified specimens for cryo-
TEM were prepared by a blotting procedure, performed in a
chamber with controlled temperature and humidity using a
LEICA grid plunger. A drop of the sample solution (1 g/L) was
placed onto an EM grid coated with a holey carbon film (C-flat,
Protochips Inc., Raleigh, NC, USA). Excess solution was then
removed with a filter paper, leaving a thin film of the solution
spanning the holes of the carbon film on the EM grid. Vitrifica-
tion of the thin film was achieved by rapid plunging of the grid
into liquid ethane held just above its freezing point. The vitrified
specimen were kept below 108 K during both transfers to the
microscope and investigation. Specimens were examined with
a LIBRA 120 PLUS instrument (Carl Zeiss Microscopy GmbH,
Oberkochen, Germany), operating at 120 kV. The microscope is
equipped with a Gatan 626 cryotransfer system. Images were
taken with a BM-2k-120 dual-speed on axis SSCCD camera (TRS,
Moorenweis, Germany).
The negatively stained sampleswere prepared by spreading
5 μL of the dispersion onto a Cu grid coated with a Formvar-film
(PLANO, Wetzlar, Germany). After 1 min, excess liquid was
blotted off with filter paper and 5 μL of a 1% aqueous uranyl
acetate solution was placed onto the grid and drained off after
1 min. The dried specimens were examined with an EM 900
transmission electron microscope (Carl Zeiss Microscopy
GmbH). Micrographs were taken with an SSCCD SM-1k-120
camera (TRS, Moorenweis, Germany).
The images were analyzed with Igor Pro 6.31 using the
ImageAnalyzeParticles operation or manual detection of re-
gions of interest. The circularity of the ROIs was defined by
the ratio of the square of the perimeter to 4π A, where A is the
object area. For a perfect circle the value 1 is approached, while
elongated objects result in values larger than 1.
Small-Angle Neutron Scattering. SANS experiments were carried
out at KWS-1, Forschungsneutronenquelle Heinz Maier-Leibnitz,
FRM II, in Garching. A wavelength of λ = 6.9 Å (Δ λ/λ = 10%)
and sampledetector distances (SDD) of 1.72, 7.72, and 19.72
m were used, which resulted in a q-range of 0.0020.221 Å1.
The detector was a 6Li glass scintillation detector with an active
area of 60 60 cm. Exposure times were 5min at SDD = 1.72 m,
15min at SDD= 7.72, and 30min at SDD = 19.72m. The samples
were mounted in Hellma quartz cuvettes with a light path of
2 mm in an oven. This oven was made from aluminum with a
plastic cover and was temperature controlled by a Julabo
thermostat. The experiments were performed at a physiological
temperature of 37 C. The scattering of boron carbide was used
for correcting the intensities for dark current and background.
The scattering of D2O and the empty cell were subtracted from
the sample scattering, taking the transmissions into account.
The resulting intensities were azimuthally averaged. Good
agreement was found in the overlap region of the curves
measured of all SDDs. All data reduction was performed with
the software QtiKWS provided by JCNS.
Samples were prepared in D2Owith concentrations as given
in Table 3. The fitting procedures were written in IGOR Pro with
the NIST NCNR SANS analysis package.43
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